2nd Quarter - Report

DLA PIPER LLP (US) for NOVO NORDISK INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization.

LobbyistCovered position, as disclosed
MEGHAN BARRON New —
NATHANIEL JAMES BELL New Senior Legislative Assistant, Rep. Robert Andrews
NICOLE CARELLI —
SARAH DONOVAN New —
SARA FRIEDMAN New —
MARY BETH LANGOWSKI —
PIPER NIETERS SU —
STEVEN R PHILLIPS —
BETH ALLISON SCHWANKE New —
JOHN SLOTMAN —
TIFFANI WILLIAMS —

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to Medicare and Medicaid drug rebates.

LobbyistCovered position, as disclosed
MEGHAN BARRON New —
NATHANIEL JAMES BELL New Senior Legislative Assistant, Rep. Robert Andrews
NICOLE CARELLI —
SARAH DONOVAN New —
SARA FRIEDMAN New —
MARY BETH LANGOWSKI —
PIPER NIETERS SU —
JOHN SLOTMAN —
TIFFANI WILLIAMS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Pharmacy PHA

H.R. 5657, Food and Drug Administration Reform Act of 2012; S. 3187, FDA Safety and Innovation Act.

LobbyistCovered position, as disclosed
MARY BETH LANGOWSKI —
PIPER NIETERS SU —
JOHN SLOTMAN —
TIFFANI WILLIAMS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5657 (112th), S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.